Screening & Assessment
How the PCRES fits into existing neurosurgical follow-up alongside PHQ-9, GAD-7, and MoCA.
Current Screening Practice
Most neurosurgical practices do not use standardized emotional screening at follow-up. When screening is performed, it typically relies on the PHQ-9 and/or GAD-7 — instruments designed for primary care depression and anxiety detection, not post-surgical recovery.
MoCA is sometimes used for cognitive screening but is not routinely administered post-craniotomy unless deficits are clinically suspected. The result is that the emotional and cognitive dimensions of recovery are either unmeasured or measured with instruments that were not designed for this population.
Why General Instruments Are Insufficient
PHQ-9 Limitations in Craniotomy Patients
The PHQ-9 conflates neurological symptoms with depression symptoms. Fatigue, concentration difficulty, and sleep changes can all be direct effects of surgery and recovery — not depression. A patient experiencing neurofatigue (a distinct neurological phenomenon) will score high on PHQ-9 items about “feeling tired” and “trouble concentrating” without being depressed. This leads to misclassification and, potentially, inappropriate treatment.
GAD-7 Limitations in Craniotomy Patients
The GAD-7 does not capture the specific anxieties of post-craniotomy life: fear of tumor recurrence, fear of personality change, grief over lost abilities, or the existential recalibration that follows brain surgery. These are not generalized anxiety — they are recovery-specific concerns that require recovery-specific assessment.
MoCA Limitations in Craniotomy Patients
The MoCA tests cognitive function in a controlled, quiet office setting. It does not measure whether a patient can function cognitively in real-world conditions — following a multi-person conversation, managing competing tasks at work, or making decisions under fatigue. A normal MoCA score does not mean normal cognitive function in daily life.
What None of These Instruments Ask
- Do you still feel like yourself?
- Does your medical progress match how you actually feel?
- Are you grieving abilities you’ve lost?
- Is your fatigue different from anything you’ve experienced before?
- Do you feel heard by your medical team?
- Do you see a path forward?
These are the questions the PCRES asks. They are not peripheral concerns — they are the substance of recovery.
The Complementary Screening Model
The PCRES is not a replacement for PHQ-9, GAD-7, or MoCA. It is a complement that captures what they cannot. The recommended workflow integrates all instruments:
This model uses the PCRES as the primary emotional screen, then deploys PHQ-9 or GAD-7 only when PCRES results suggest depression or anxiety may be present alongside recovery-specific concerns. This reduces unnecessary screening while ensuring nothing is missed.
Instrument Comparison
| Instrument | What It Measures | What It Misses in Craniotomy Patients |
|---|---|---|
| PHQ-9 | Depression severity (DSM criteria) | Identity disruption, neurofatigue, medical-experience gap, grief that is not depression |
| GAD-7 | Anxiety severity | Cognitive overwhelm, social withdrawal from neurological cause, loss of agency |
| MoCA | Cognitive screening (memory, attention, language) | Real-world functional cognition, emotional regulation, self-continuity |
| SF-36 | General health-related quality of life | Not specific to neurosurgical recovery; too broad to guide clinical action |
| EORTC QLQ-BN20 | Brain tumor-specific symptoms | Disease-focused, not recovery-experience-focused; misses emotional trajectory |
| PCRES | Recovery-specific emotional experience across 8 domains | Designed specifically for what the instruments above cannot capture |
Interpretation Guidance
The PCRES is not a diagnostic instrument. It is a clinical conversation starter and longitudinal tracking tool. Domain scores indicate areas warranting clinical attention, not diagnoses.
- Domain flags identify specific recovery concerns that merit clinical conversation
- The two open-ended questions (items 36–37) often reveal concerns that structured items miss
- The global quality-of-life rating provides a patient-anchored benchmark for tracking over time
- Score changes over time reveal recovery trajectory and identify patients who are stalling or declining
Recommended Assessment Timeline
Early recovery — establishes starting point for all domains
Acute recovery transition — identifies early divergence between medical and emotional trajectories
Most patients are returning to daily activities — real-world cognition and social domains become salient
Grief and identity domains often peak here as the “new normal” sets in
Establishes long-term recovery profile — identifies patients with persistent impairment
Practical Integration Tips
Waiting room completion: Patients can complete the PCRES on their phone via QR code or on paper while waiting. Results are available before the clinician enters the room.
Results before the visit: Online completion emails results directly to the provider, allowing review before the appointment begins.
Clinical documentation: Domain scores and flags can be documented in the clinical note in a single line: PCRES: A-72 B-65 C-50 D-44 E-55 F-80 G-38 H-70 | Total: 58% | Flags: G(Alert), D(Monitor)
Flag-triggered actions: Clinical flags give specific next steps, not just a number. See the Clinical Reference for the complete flag action table.